Overview Indicated for the treatment of subclinical mastitis caused by susceptible strains of Staphlycoccus aureus and Streptococcus agalactiae in dry cows.

  • Provides synergistic antibiotic combination of penicillin and novobiocin
  • Batericidal activity against major Staphlococcus and Streptococcus mastitis pathogens
  • Ideal duration of activity during the involution phase of the dry cow period, when the keatin plug has not formed and the cow is susceptible to infections
  • Contents of one syringe are infused into each quarter at dry off
  • 72-hour milk withhold following calving
  • 30-day preslaughter withdrawal required following administration